Li W, Fei K, Guo L, Wang Y, et al. CD74/SLC34A2-ROS1 fusion variants involving the transmembrane region predict poor response to crizotinib in non-small cell lung cancer independent of TP53 mutations. J Thorac Oncol 2023 Dec 7:S1556-0864(23)02414.
PMID: 38070598